mecamylamine has been researched along with Anochlesia in 10 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nicotine has been reported to potentiate the cataleptic effect of the dopamine receptor antagonist haloperidol in rats." | 1.31 | Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms. ( Boye, SM; Clarke, PB, 2000) |
| "Mecamylamine pretreatment reduced the morphine- and haloperidol-induced elevation of striatal HVA concentrations." | 1.26 | Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol. ( Ahtee, L; Kaakkola, S, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wadenberg, ML | 1 |
| Fjällström, AK | 1 |
| Federley, M | 1 |
| Persson, P | 1 |
| Stenqvist, P | 1 |
| Zarrindast, MR | 1 |
| Haeri-Zadeh, F | 1 |
| Zarghi, A | 1 |
| Lahiji, P | 1 |
| Boye, SM | 1 |
| Clarke, PB | 1 |
| Sanberg, PR | 1 |
| Newman, MB | 1 |
| Manresa, JJ | 1 |
| Potts, SE | 1 |
| Alvarez, F | 1 |
| Cahill, DW | 1 |
| Shytle, RD | 1 |
| Ahtee, L | 2 |
| Kaakkola, S | 1 |
| Mason, ST | 1 |
| Klemm, WR | 1 |
| Hatch, RC | 1 |
| Zetler, G | 1 |
| Thörner, R | 1 |
10 other studies available for mecamylamine and Anochlesia
| Article | Year |
|---|---|
Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Cholinergic Antagoni | 2011 |
Nicotine potentiates sulpiride-induced catalepsy in mice.
Topics: Animals; Antipsychotic Agents; Atropine; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism | 1998 |
Enhancement of haloperidol-induced catalepsy by nicotine: an investigation of possible mechanisms.
Topics: Animals; Catalepsy; Chlorisondamine; Cotinine; Dopamine Antagonists; Drug Synergism; Haloperidol; Ma | 2000 |
Mecamylamine effects on haloperidol-induced catalepsy and defecation.
Topics: Animals; Antipsychotic Agents; Catalepsy; Defecation; Drug Synergism; Haloperidol; Male; Mecamylamin | 2001 |
Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
Topics: Animals; Catalepsy; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Homovanillic Acid; Hu | 1978 |
Central noradrenergic--cholinergic interaction and locomotor behavior.
Topics: Acetylcholine; Animals; Arecoline; Catalepsy; Humans; Hydroxydopamines; Hypothalamus; Male; Mecamyla | 1979 |
Effect of cholingeric drugs on methadone-induced catalepsy and stereotypies in rats treated chronically with methadone.
Topics: Animals; Atropine; Behavior; Catalepsy; Drug Synergism; Hexamethonium Compounds; Humans; Male; Mecam | 1976 |
Evidence for a cholinergic role in haloperidol-induced catalepsy.
Topics: Animals; Atropine; Brain; Catalepsy; Cholinergic Fibers; Drug Synergism; Haloperidol; Hemicholinium | 1985 |
Ketamine catalepsy and anesthesia in dogs pretreated with antiserotonergic or antidopaminergic neuroleptics or with anticholinergic agents.
Topics: Anesthesia; Animals; Atropine; Catalepsy; Chlorpromazine; Dibenzothiepins; Dihydroxyphenylalanine; D | 1974 |
Drug-induced catalepsy as influenced by psychostimulants, apomorphine, L-dopa, and yohimbine.
Topics: Amphetamine; Animals; Apomorphine; Catalepsy; Dihydroxyphenylalanine; Hallucinogens; Haloperidol; Hu | 1973 |